VOR - Voyager Therapeutics appoints Nathan Jorgensen as CFO
2024-06-13 07:22:19 ET
More on Voyager Therapeutics
- Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis
- Voyager Therapeutics up 8% following quarterly beats
- Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M
- Seeking Alpha’s Quant Rating on Voyager Therapeutics